Adriacin and hepatotoxicity Patient Reports February 12, 2012

Adriacin Side Effects Report #4567466-8
Adriacin side effect was reported by a Consumer or non-health professional from on Jan 17, 2005. Male patient, 66 years of age, weighting 125.7 lb, was diagnosed with lymphoma  and was treated with Adriacin. After drug was administered, patient experienced the following side effects: cholestasis, hepatotoxicity. Adriacin dosage: 58 MG (58 MG, 1 D), INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, PREDNISOLONE. Patient was hospitalized. Patient recovered.